BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Diagnosis
5 results:

  • 1. The Prognostic Significance of Selected HLA Alleles on prostate cancer Outcome.
    Stokidis S; Baxevanis CN; Fortis SP
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833904
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A prospective and population-based inquiry on the use and acceptability of peer support for women newly diagnosed with breast cancer.
    Legg M; Hyde MK; Occhipinti S; Youl PH; Dunn J; Chambers SK
    Support Care Cancer; 2019 Feb; 27(2):677-685. PubMed ID: 30056530
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Is magnetic resonance/ultrasound fusion prostate biopsy better than systematic prostate biopsy? An updated meta- and trial sequential analysis.
    Wu J; Ji A; Xie B; Wang X; Zhu Y; Wang J; Yu Y; Zheng X; Liu B; Xie L
    Oncotarget; 2015 Dec; 6(41):43571-80. PubMed ID: 26498362
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [cancer mortality in Southern Italy, 1999-2003].
    Bidoli E; Montella M; Bruzzone S; De Paoli A; Fusco M; Frova L; Pace M; Pappagallo M; Serraino D
    Epidemiol Prev; 2011; 35(3-4):200-6. PubMed ID: 21914916
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma.
    Helgadottir H; Andersson E; Villabona L; Kanter L; van der Zanden H; Haasnoot GW; Seliger B; Bergfeldt K; Hansson J; Ragnarsson-Olding B; Kiessling R; Masucci GV
    Cancer Immunol Immunother; 2009 Oct; 58(10):1599-608. PubMed ID: 19214504
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.